MPWT
ZNTL icon

MassMutual Private Wealth & Trust’s Zentalis Pharmaceuticals ZNTL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16
Closed -$1K – 1744
2022
Q1 		$1K Buy
+16
New +$863 ﹤0.01% 1461

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

MassMutual Private Wealth & Trust's ZNTL Position: Q2 2022 in Review

MassMutual Private Wealth & Trust sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2022, closing a stake of 16 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in ZNTL in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 122 funds tracked by Wall St. Rank hold ZNTL as of Q2 2022.

  • MassMutual Private Wealth & Trust reported no remaining Zentalis Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 16 Zentalis Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Zentalis Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Zentalis Pharmaceuticals position peaked at $1K in Q1 2022.
  • 122 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2022, filed 7 Jul 2022.